Evolus (EOLS) Net Equity Issued and Repurchased (2017 - 2026)
Evolus (EOLS) recorded Net Equity Issued and Repurchased of $145,000 in Q3 2026, up 705.6% from $18,000 a year earlier but down 53.7% from the prior quarter.
Powered by 
Analysis
Evolus (EOLS) Net Equity Issued and Repurchased (2017 - 2026) Analysis & Trends
On a TTM basis, Evolus' Net Equity Issued and Repurchased came in at $539,000 as of Sep 30, 2026, down 79.2% year-over-year; for FY2025, it was $1.16 million, down 97.9% from FY2024.
- Annual Net Equity Issued and Repurchased has a four-year compound annual growth rate of 15.5% (FY2021 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $56.09 million in FY2024, $231,000 in FY2023 (-57.1%), $539,000 in FY2022 (-17.7%) and $655,000 in FY2021.
- Quarterly Net Equity Issued and Repurchased has ranged from $1,000 in Q4 2021 to $47.49 million in Q1 2024 over the past five years.
- On a year-over-year basis, Net Equity Issued and Repurchased rose in 1 of the last six quarters, with growth averaging 52.9%.
- Peak year-over-year performance for Net Equity Issued and Repurchased in the last five years was growth of 881.7% in Q3 2024, against a decline of 98.4% in Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Evolus | 450.43 Mn | 259.94 Mn | 50.69 Mn | 145,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 145,000.00 |
| Jun 30, 2026 | 313,000.00 |
| Dec 31, 2025 | 81,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 323,000.00 |
| Mar 31, 2025 | 742,000.00 |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 589,000.00 |
| Jun 30, 2024 | 6.51 Mn |
| Mar 31, 2024 | 47.49 Mn |
| Dec 31, 2023 | 36,000.00 |
| Sep 30, 2023 | 60,000.00 |
| Jun 30, 2023 | 109,000.00 |
| Mar 31, 2023 | 26,000.00 |
| Jun 30, 2022 | 167,000.00 |
| Mar 31, 2022 | 17,000.00 |
| Sep 30, 2021 | 8.95 Mn |
| Jun 30, 2021 | 644,000.00 |
| Mar 31, 2021 | 11,000.00 |
| Dec 31, 2019 | 74.66 Mn |
API Access
Evolus Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EOLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();